Market Access Strategy
Achieving successful market access requires more than strong clinical data. It relies on a comprehensive evidence package that addresses the needs of different stakeholders, markets
and healthcare systems.
At Maverex, we combine multi-disciplinary expertise with a deep understanding of
decision-maker priorities to design high-quality, impactful, and stakeholder-focused market access strategy solutions at each stage of the product life cycle.
“The whole team are extremely pleased with the work. A partner we can trust.”
Health Economics Director, Top Five Global Biopharma Company
What We Offer
Strategic advice coupled with scientific rigour
We work with our clients to identify key evidence gaps and develop structured and comprehensive plans for evidence generation, stakeholder engagement, and publications.
We also collaborate with external experts to provide insights and validate our strategic solutions, ensuring they reflect real-world needs.
By aligning strategic activities with product development timelines and adapting quickly as priorities change, we support our clients in increasing the likelihood of positive reimbursement outcomes, timely patient access, and long-term value maximisation.
Who We Are
A team of experienced professionals, focused on high-quality solutions and a commitment to environmental responsibility.
Benefits of Defining a Clear Market Access Strategy
A deep understanding of payer, clinician, and patient needs
by reviewing client materials, scientific literature, and previous HTA decisions to understand the evidence base, disease context, competitive environment, payer expectations, and potential access barriers
Early identification and mitigation of access barriers
by critically evaluating available data to identify strengths, limitations, and priority evidence gaps that may impact value communication and payer decision-making
A structured, evidence-led, and multi-disciplinary approach to evidence generation
by working cross-functionally to design a robust evidence generation plan, stakeholder engagement, and publication strategy, aligned with development milestones and launch timelines
Strengthened engagement with priority stakeholders across the product lifecycle
by engaging early with key stakeholders including payers, clinicians, and patients to pressure-test value propositions, validate evidence priorities and ensure the strategy reflects real-world decision needs
Aligned global, regional, and local teams with a shared strategic vision
by bringing together internal stakeholders from market access, medical, regulatory and key country affiliates to review and refine the strategy, ensuring buy-in and consistent execution across markets
Increased confidence and probability of positive pricing and reimbursement outcomes
by defining a clear approach to evidence generation, publication planning, and stakeholder engagement
Evidence Generation and Early Planning
Health economic modelling
Evidence synthesis
Real-world evidence
Market access validation
Market access strategy
Evidence generation plans
Stakeholder mapping
Payer landscaping
Communicating Value and Engaging Parties
Objection handlers
Interactive global value dossiers
Value message validation
Stakeholder engagement
Evidence synthesis
Real-world evidence
Market access validation
Value message materials
…As well as HTA submission preparation, support, and advice
Our Services
From Real World Evidence and Environmental Impact Analysis, through to Market Access Materials and more. Maverex are perfectly positioned to support global Pharma and MedTech companies achieve success.
Much more to Maverex
Experts in demonstrating product value, from clinical development to post-launch commercialisation.
-
Explore our latest peer-reviewed research publications, across nutrition, disease, the environment, market access and much more.
-
We take a personal approach to every project, and enjoy fantastic feedback from our clients as a result. Discover what they have to say about us on the Testimonials page.